Current human studies have not shown an increased overall cancer risk with GLP-1 medications
69 In addition to its use in diabetes management, GLP-1RA has also shown potential in other areas of research
Together, we are one health system over 24,000 members strong, from 11 hospitals, more than 250 medical offices, 9 cancer centers, 21 imaging centers, 5 health parks, and 15 urgent care centers
Pricing and medication details are disclosed after intake rather than on public pages
Novo is also working with Gilead on a once-weekly subcutaneous version of semaglutide, which is currently in a phase 3 trial
Be very cautious about OTC products marketed as GLP-1 alternatives most lack clinical evidence